Attached files
| file | filename |
|---|---|
| EX-10.39 - EX-10.39 - Tracon Pharmaceuticals, Inc. | d309060dex1039.htm |
| EX-5.1 - EX-5.1 - Tracon Pharmaceuticals, Inc. | d309060dex51.htm |
| S-1 - S-1 - Tracon Pharmaceuticals, Inc. | d309060ds1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-1) and related Prospectus of TRACON Pharmaceuticals, Inc. for the registration of 3,231,515 shares of common stock, and to the incorporation by reference therein of our report dated February 28, 2017, with respect to the financial statements of TRACON Pharmaceuticals, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2016, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
San Diego, California
March 24, 2017